Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge
- PMID: 1830113
- PMCID: PMC248864
- DOI: 10.1128/JVI.65.8.4263-4274.1991
Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge
Abstract
cDNA clones of the genes encoding either the hemagglutinin (HA) or fusion (F) proteins of the Edmonston strain of measles virus (MV) were expressed in vaccinia virus recombinants. Immunofluorescence analysis detected both proteins on the plasma membranes of unfixed cells as well as internally in fixed cells. Immunoprecipitation of metabolically radiolabeled infected-cell extracts by using specific sera demonstrated a 76-kDa HA polypeptide and gene products of 60, 44, and 23 kDa which correspond to a MV F precursor and cleavage products F0, F1, and F2, respectively. Neither recombinant induced cell fusion of Vero cells when inoculated individually, but efficient cell fusion was readily observed upon coinfection of cells with both recombinants. Inoculation of dogs with the vaccinia virus-MV F recombinant (VV-MVF) did not give rise to detectable MV-neutralizing antibody. Inoculation of dogs with the vaccinia virus-MV HA recombinant (VV-MVHA) or coinoculation with both recombinants (VV-MVF and VV-MVHA) induced significant MV-neutralizing titers that were increased following a booster inoculation. Inoculation of dogs with the vaccinia virus recombinants or with MV failed to induce canine distemper virus (CDV)-neutralizing antibodies. Upon challenge with a lethal dose of virulent CDV, signs of infection were observed in dogs inoculated with (VV-MVF). No symptoms of disease were observed in dogs that had been vaccinated with VV-MVHA or with VV-MVHA and VV-MVF and then challenged with CDV. All dogs vaccinated with the recombinant viruses as well as those inoculated with MV or a vaccine strain of CDV survived CDV challenge.
Similar articles
-
Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.Virology. 1992 Mar;187(1):321-8. doi: 10.1016/0042-6822(92)90321-f. Virology. 1992. PMID: 1736535
-
Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens.Vaccine. 1993;11(4):438-44. doi: 10.1016/0264-410x(93)90285-6. Vaccine. 1993. PMID: 8470428
-
Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.J Gen Virol. 1992 Feb;73 ( Pt 2):359-67. doi: 10.1099/0022-1317-73-2-359. J Gen Virol. 1992. PMID: 1538193
-
Safety and Immunogenicity of Morbillivirus canis Vaccines for Domestic and Wild Animals: A Scoping Review.Viruses. 2024 Jul 4;16(7):1078. doi: 10.3390/v16071078. Viruses. 2024. PMID: 39066240 Free PMC article. Review.
-
Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity.Virus Genes. 2003 Dec;27(3):269-82. doi: 10.1023/a:1026399916888. Virus Genes. 2003. PMID: 14618088 Review.
Cited by
-
Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation.J Virol. 1994 Oct;68(10):6770-4. doi: 10.1128/JVI.68.10.6770-6774.1994. J Virol. 1994. PMID: 8084012 Free PMC article.
-
Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.mBio. 2020 Jul 7;11(4):e00972-20. doi: 10.1128/mBio.00972-20. mBio. 2020. PMID: 32636246 Free PMC article.
-
Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.J Clin Microbiol. 1998 Mar;36(3):721-6. doi: 10.1128/JCM.36.3.721-726.1998. J Clin Microbiol. 1998. PMID: 9508302 Free PMC article.
-
A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.Hum Vaccin Immunother. 2012 Jul;8(7):961-70. doi: 10.4161/hv.21080. Epub 2012 Jul 1. Hum Vaccin Immunother. 2012. PMID: 22777090 Free PMC article. Review.
-
Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.J Virol. 2002 Jan;76(2):484-91. doi: 10.1128/jvi.76.2.484-491.2002. J Virol. 2002. PMID: 11752138 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous